KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,021,607 | +10.9% | 209,928 | +3.6% | 0.00% | – |
| Q2 2023 | $1,823,607 | +21.0% | 202,623 | +5.7% | 0.00% | – |
| Q1 2023 | $1,507,359 | -73.3% | 191,776 | -77.0% | 0.00% | -100.0% |
| Q4 2022 | $5,636,171 | +1158.1% | 833,753 | +2599.8% | 0.00% | – |
| Q3 2022 | $448,000 | -23.3% | 30,882 | -47.9% | 0.00% | – |
| Q2 2022 | $584,000 | -41.2% | 59,319 | -12.0% | 0.00% | – |
| Q1 2022 | $993,000 | +18.9% | 67,379 | +6.8% | 0.00% | – |
| Q4 2021 | $835,000 | +178.3% | 63,084 | +268.5% | 0.00% | – |
| Q3 2021 | $300,000 | +27.7% | 17,121 | +74.4% | 0.00% | – |
| Q2 2021 | $235,000 | -69.3% | 9,815 | -67.1% | 0.00% | – |
| Q1 2021 | $766,000 | +228.8% | 29,815 | +142.4% | 0.00% | – |
| Q4 2020 | $233,000 | +269.8% | 12,302 | +143.5% | 0.00% | – |
| Q3 2020 | $63,000 | -16.0% | 5,052 | -18.2% | 0.00% | – |
| Q2 2020 | $75,000 | -50.3% | 6,179 | -68.8% | 0.00% | – |
| Q1 2020 | $151,000 | -55.2% | 19,792 | +4.7% | 0.00% | – |
| Q4 2019 | $337,000 | -24.1% | 18,896 | -50.7% | 0.00% | – |
| Q3 2019 | $444,000 | +2014.3% | 38,319 | +3972.2% | 0.00% | – |
| Q2 2019 | $21,000 | -90.2% | 941 | -87.4% | 0.00% | – |
| Q1 2019 | $214,000 | +1158.8% | 7,486 | +780.7% | 0.00% | – |
| Q4 2018 | $17,000 | -81.7% | 850 | -79.8% | 0.00% | – |
| Q3 2018 | $93,000 | +1450.0% | 4,202 | +450.0% | 0.00% | – |
| Q2 2018 | $6,000 | – | 764 | +1763.4% | 0.00% | – |
| Q1 2018 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 41 | -79.5% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 200 | -50.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |